EU Approves Kimberly-Clark's $48.7 Billion Kenvue Acquisition

· Beauty & Fashion · United States · European Union

The European Union on Tuesday, October 13, approved Kimberly-Clark's $48.7 billion purchase of Kenvue, the consumer health company behind Neutrogena. The clearance came after Kimberly-Clark agreed to divest feminine hygiene brands in Europe to keep those products affordable for consumers. Kimberly-Clark, based in Texas, makes a wide range of paper and fabric-based products and is best known for household and personal care names. Kenvue was spun off from Johnson & Johnson and carries a portfolio that spans skin care and consumer health. The merged group would create one of the largest consumer and personal care players, with a far bigger beauty and skin care footprint than Kimberly-Clark has held before. EU approval was the key regulatory hurdle; attention now turns to remaining jurisdictions and integration planning. For the beauty trade, the deal reshapes competitive scale in mass skin care and pharmacy-channel brands across Europe.

Why it matters：The deal redraws the competitive map in mass-market skin care and consumer health, giving a household-products giant control of pharmacy-channel beauty brands and setting a precedent for how EU competition remedies shape future beauty M&A.

Key points

  • Kimberly-Clark agreed to divest European feminine hygiene brands as a condition of clearance.
  • Kenvue was spun off from Johnson & Johnson and owns Neutrogena.
  • The $48.7 billion deal creates a much larger beauty and personal care footprint for Kimberly-Clark.

Sources (original reporting)

More stories from this day